Business continuity management is a key success contributor to the pharma industry. As an industry leader, we will share our business continuity plan principles for a safe and robust supply chain. As an example, we will discuss the Benzonase® BCP and safety-stock build-up strategy from 2019-2023. During Covid-19, more than 2 Billion vaccine doses were manufactured using this product family. This would not have been possible without a multi-year planning strategy.
We'll describe why this product has one of the strongest supply chains in the industry.
In this webinar, you will learn:
- Key principles of Business Continuity Management
- Best practices for a robust supply chain
- How it translates into success stories, like with the Benzonase® family.
Speakers
Andrew Goldman
Merck
Head of Business Continuity Management
Andrew leads the business continuity management program for Merck. In this role, he is responsible for the development, maintenance, and reporting of supply chain risks and business continuity plans. Andrew holds an MBA and has more than 20 years of experience in supply chain management.
Sarah Lechat
Merck
Global Strategic Marketing Manager
Sarah is a global strategic marketing manager for Merck, specializing in manufacturing enzymes and downstream chemicals. She uses her expertise serving novel modalities markets (VGT, mRNA, …) and bringing to life new innovative solutions to meet their manufacturing needs. She has worked in the pharmaceutical industry for more than 10 years and has held a number of roles in this capacity worldwide, including bioproduct development & regulatory consultancy for exporting biotech companies.
Sarah holds a master's degree in molecular & cell biology (specializing in cell & gene therapy) from the UPMC and Ecole Normale Supérieure de Paris. She also holds a master's degree in health marketing & market access from the Sorbonne University.
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
期间:1h
语言:English
场次 1:往期 April 18, 2024
如要继续阅读，请登录或创建帐户。
暂无帐户？